Related Experiment Video

Updated: Aug 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty

R Bach1, F Jung, I Kohsiek

  • 1Department of Clinical Haemostasiology and Transfusion Medicine, University of Saarland, Homburg/Saar.

Thrombosis Research
|January 1, 1994
PubMed

Insights

Abnormal platelet function and diabetes mellitus significantly increase restenosis rates after percutaneous transluminal coronary angioplasty (PTCA). These factors are key predictors of restenosis, impacting patient outcomes six months post-procedure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure to treat coronary artery stenosis.
  • Restenosis, the re-narrowing of the treated artery segment, remains a significant complication following PTCA.
  • Identifying factors that predict restenosis is crucial for improving patient outcomes and optimizing treatment strategies.

Purpose of the Study:

  • To investigate the restenosis rate six months after successful PTCA.
  • To identify clinical and biological factors associated with the development of restenosis.
  • To determine the predictive value of platelet function and diabetes mellitus on restenosis post-PTCA.

Main Methods:

  • A prospective open study involving 131 patients (99 men, 32 women) undergoing successful PTCA.
  • Follow-up angiographies were performed at six months post-procedure.
  • Patient data including age, sex, comorbidities (diabetes, hypertension), lipid metabolism, smoking status, aspirin dosage, pre-PTCA stenosis degree, number of dilated segments, and platelet reactivity were analyzed.

Main Results:

  • The overall restenosis rate was 30% (39 out of 131 patients) at six months.
  • Restenosis rates varied significantly with platelet function: 25% (normal), 50% (mildly abnormal), and 60% (frankly abnormal).
  • Diabetic patients exhibited a higher restenosis rate (45%) compared to non-diabetic patients (24%).
  • Abnormal platelet function and diabetes mellitus were identified as the most significant predictors of restenosis.
  • Pre-angioplasty stenosis degree also showed a notable association with restenosis.

Conclusions:

  • Abnormal platelet function and diabetes mellitus are critical determinants of restenosis following successful PTCA.
  • Platelet reactivity assessment and careful management of diabetes are essential in patients undergoing angioplasty.
  • These findings underscore the importance of personalized risk assessment and management strategies to mitigate restenosis after PTCA.

More Related Videos

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...